QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

22,715 signal articles · 206 in last 24h · 109,001 total before filter · latest 13m ago
206last 24h
2544last 7d
481● bullish (7d)
241● bearish (7d)
202publishers
AllMacro231Earnings1585M&A104Regulatory18Product12Analyst23
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Charles Schwab (SCHW) Could Be 15% Undervalued As Earnings Buybacks And Dividends Impress
Simply Wall St.11d agobullish
Charles Schwab (SCHW) Could Be 15% Undervalued As Earnings Buybacks And Dividends Impress

Charles Schwab (SCHW) just combined three shareholder friendly moves: a higher second quarter earnings print, fresh buyback progress, and confirmed common and preferred dividends, giving investors new information on both growth and income potential. See our latest analysis for Charles Schwab. At a share price of $104.47, Charles Schwab’s recent 30 day share price return of 15.37% and 90 day share price return of 14.00% sit alongside a 1 year total shareholder return of 7.33%, while the 3 year...

Banco Bilbao Viscaya Argentaria Q2 Earnings Call Highlights
MarketBeat11d agoneutral
Banco Bilbao Viscaya Argentaria Q2 Earnings Call Highlights

Banco Bilbao Viscaya Argentaria (NYSE:BBVA) reported record second-quarter earnings, supported by loan growth, higher core revenues and improved capital generation, while announcing a new €2 billion extraordinary share repurchase program. Net attributable profit reached €3.062 billion in the second

Diners Return To Chipotle, Giving Earnings And Stock A Lift
Benzinga11d agoneutral
Diners Return To Chipotle, Giving Earnings And Stock A Lift

Chipotle Mexican Grill Inc. (NYSE:CMG) stock rose in premarket trading Thursday after the restaurant chain reported second-quarter results that topped Wall Street estimates, driven by higher comparable sales and increased customer traffic. Earnings Beat Estimates Adjusted earnings were 33 cents per share, topping the analyst consensus estimate of 32 cents, according to Benzinga Pro. Revenue increased 9.3% year over year to $3.35 billion, ahead of the consensus estimate of $3.33 billion. Comparab

DocuSign (DOCU) Could Be 3% Undervalued On Its Latest Earnings Setup
Simply Wall St.11d agoneutral
DocuSign (DOCU) Could Be 3% Undervalued On Its Latest Earnings Setup

DocuSign (DOCU) has drawn fresh attention after becoming one of the most searched stocks on Zacks.com, with the company expected to report quarterly earnings of $1.08 per share and a Zacks Rank #3 rating. See our latest analysis for DocuSign. DocuSign’s recent momentum has been strong, with a 1 day share price return of 3.93% and a 30 day share price return of 29.15%. However, year to date the share price is still down 10.30% and the 1 year total shareholder return is down 25.38%, suggesting...

ASE Technology Q2 Earnings Call Highlights
MarketBeat11d agoneutral
ASE Technology Q2 Earnings Call Highlights

ASE Technology (NYSE:ASX) reported second-quarter 2026 results marked by strong growth in its assembly, testing and materials business, driven by demand for leading-edge packaging and testing services as semiconductor customers expand AI-related hardware capacity. Consolidated net revenue rose 10%

Centene (CNC) Could Be 3% Undervalued After Strong Q2 Earnings And Higher Outlook
Simply Wall St.11d agoneutral
Centene (CNC) Could Be 3% Undervalued After Strong Q2 Earnings And Higher Outlook

Centene (CNC) is back in the spotlight after its second quarter 2026 update, which combined strong earnings and a higher full year profit outlook with a sharp year over year membership decline. See our latest analysis for Centene. At a share price of US$61.82, Centene has given investors a 47.97% year to date share price return and a very large 139.71% 1 year total shareholder return, even though the share price has recently pulled back after the Q2 earnings and guidance update. If Centene's...

How Investors May Respond To Qorvo (QRVO) Earnings Beat Amid Mixed Sales And Stronger Profit Margins
Simply Wall St.11d agobullish
How Investors May Respond To Qorvo (QRVO) Earnings Beat Amid Mixed Sales And Stronger Profit Margins

Qorvo, Inc. reported past first-quarter fiscal 2027 results to June 27, 2026, with sales of US$784.8 million versus US$818.78 million a year earlier, while net income rose to US$85.8 million from US$25.59 million, lifting basic earnings per share from continuing operations to US$0.97. Despite softer smartphone-related revenue, Qorvo’s High-Performance Analog business and cost controls boosted profitability, with earnings and sales exceeding analyst consensus for the quarter. Next, we’ll...

POSCO Q2 Earnings Call Highlights
MarketBeat11d agoneutral
POSCO Q2 Earnings Call Highlights

POSCO (NYSE:PKX) Holdings reported higher second-quarter earnings as profit improved across its steel, rechargeable battery materials and energy businesses, while its Argentina lithium operation posted its first quarterly operating profit. The company recorded consolidated revenue of KRW 19.3 trill

Bayerische Motoren Werke Aktiengesellschaft Q2 Earnings Call Highlights
MarketBeat11d agobearish
Bayerische Motoren Werke Aktiengesellschaft Q2 Earnings Call Highlights

Bayerische Motoren Werke Aktiengesellschaft (ETR:BMW) said it is preparing a broad transformation program focused on streamlining processes, increasing the use of artificial intelligence and offering voluntary severance packages for indirect employees, while maintaining its production footprint in k

Merck (MRK) Stock Looks Cheap On Cash Flow But Fair On Earnings
Simply Wall St.11d agoneutral
Merck (MRK) Stock Looks Cheap On Cash Flow But Fair On Earnings

Merck stock has more than doubled over the past five years, and the latest Discounted Cash Flow (DCF) intrinsic value estimate now points to a sizeable gap versus the current share price, while the broader valuation checks suggest a more mixed picture. The roughly 102% total return over five years highlights how strongly the market has rewarded Merck over a full cycle and raises the bar for any further upside to be justified by fundamentals. Recent news around the FDA approval of the oral...

ProPetro Q2 Earnings Call Highlights
MarketBeat11d agoneutral
ProPetro Q2 Earnings Call Highlights

ProPetro (NYSE:PUMP) reported second-quarter 2026 revenue of $306 million, up 13% from the prior quarter, while its net loss widened to $8 million, or $0.07 per diluted share, from a $4 million loss in the first quarter. Adjusted EBITDA rose 23% sequentially to $45 million, equal to 15% of revenue.

Procter & Gamble Q4 Earnings Call Highlights
MarketBeat11d agoneutral
Procter & Gamble Q4 Earnings Call Highlights

Procter & Gamble (NYSE:PG) reported fiscal 2026 results within its initial guidance ranges, as modest organic sales growth, a 1% increase in core earnings per share and more than $15 billion returned to shareholders offset a volatile operating environment. The company also announced that Jon Mo

Sunrun (RUN) Stock Could Trade At A Discount On Earnings But A Premium On Broader Checks
Simply Wall St.11d agoneutral
Sunrun (RUN) Stock Could Trade At A Discount On Earnings But A Premium On Broader Checks

Sunrun stock has fallen sharply over the past few years, yet its current valuation checks and market multiples leave a more nuanced picture for investors trying to work out whether the current price around US$9.47 still makes sense. Sunrun shares are down 82.3% over 5 years, which means the market has already priced in a lot of pessimism about the business. Future growth in residential solar adoption and the company’s ability to turn that into consistent cash flows can support the investment...

Biogen (BIIB) Is Up 5.8% After Earnings Compression Amid Revenue Growth – Is Profitability Peaking?
Simply Wall St.11d agoneutral
Biogen (BIIB) Is Up 5.8% After Earnings Compression Amid Revenue Growth – Is Profitability Peaking?

Biogen Inc. has released its second-quarter 2026 results, reporting revenue of US$2.74 billion versus US$2.65 billion a year earlier, while net income dropped to US$97.5 million and diluted EPS from continuing operations fell to US$0.66 from US$4.33. Despite modest revenue growth for both the quarter and first half of 2026, Biogen’s profitability compressed sharply, with six‑month net income falling to US$417.0 million from US$875.3 million, highlighting a widening gap between sales...

Insperity Q2 Earnings Call Highlights
MarketBeat11d agoneutral
Insperity Q2 Earnings Call Highlights

Insperity (NYSE:NSP) reported second-quarter 2026 adjusted earnings per share of $0.34 and adjusted EBITDA of $36 million, exceeding the midpoint of its projected ranges. Adjusted EPS rose 31% from a year earlier, while adjusted EBITDA increased 13%, as the professional employer organization continu

L3Harris Technologies Q2 Earnings Call Highlights
MarketBeat11d agoneutral
L3Harris Technologies Q2 Earnings Call Highlights

L3Harris Technologies (NYSE:LHX) reported higher second-quarter revenue, earnings and cash flow, citing broad-based growth across its three business segments and increased international sales. The defense contractor also raised its full-year 2026 revenue and earnings-per-share outlook while maintain